ARS Pharmaceuticals (SPRY) Insider Trading & Ownership $14.69 +0.16 (+1.10%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$14.44 -0.25 (-1.70%) As of 06/10/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARS Pharmaceuticals (NASDAQ:SPRY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)11Amount OfInsider Selling(Last 12 Months)$40.28M Get SPRY Insider Trade Alerts Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRY Insider Buying and Selling by Quarter ARS Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/20/2025Alexander A FitzpatrickInsiderSell102,969$14.10$1,451,862.90 5/20/2025Brent L. SaundersDirectorSell120,000$14.25$1,710,000.00 5/20/2025Kathleen D ScottCFOSell50,000$14.10$705,000.00 4/7/2025Laura ShawverDirectorSell50,002$12.30$615,024.60 3/20/2025Eric KarasInsiderSell10,000$14.00$140,000.00 3/6/2025Laura ShawverDirectorSell49,600$11.21$556,016.00 2/3/2025Laura ShawverDirectorSell50,000$12.31$615,500.00 1/6/2025Laura ShawverDirectorSell50,000$11.10$555,000.00 12/17/2024Sarina TanimotoInsiderSell100,000$11.67$1,167,000.00 12/13/2024Justin ChakmaInsiderSell27,272$12.06$328,900.32 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/12/2024Brian DorseyCOOSell25,000$12.30$307,500.00 12/10/2024Sarina TanimotoInsiderSell100,000$13.16$1,316,000.00 12/6/2024Justin ChakmaInsiderSell50,000$14.23$711,500.00 12/4/2024Laura ShawverDirectorSell14,772$13.75$203,115.00 12/3/2024Justin ChakmaInsiderSell45,000$13.19$593,550.00 12/2/2024Laura ShawverDirectorSell97,244$13.56$1,318,628.64 11/27/2024Justin ChakmaInsiderSell25,000$14.39$359,750.00 11/25/2024Justin ChakmaInsiderSell32,814$14.00$459,396.00 11/11/2024James E FlynnMajor ShareholderSell528,456$18.04$9,533,346.24 10/16/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 10/15/2024Sarina TanimotoInsiderSell100,000$14.88$1,488,000.00 10/8/2024Richard E LowenthalCEOSell100,000$13.83$1,383,000.00 9/18/2024Eric KarasInsiderSell10,000$14.00$140,000.00 9/17/2024Richard E LowenthalCEOSell100,000$12.93$1,293,000.00 8/26/2024Peter A ThompsonDirectorSell83,695$13.00$1,088,035.00 8/23/2024Peter A ThompsonDirectorSell69,500$13.03$905,585.00 8/21/2024Peter A ThompsonDirectorSell407,700$13.56$5,528,412.00 8/20/2024Brian DorseyCOOSell50,000$15.00$750,000.00 8/20/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 8/20/2024Richard E LowenthalCEOSell100,000$15.03$1,503,000.00 8/19/2024Eric KarasInsiderSell10,000$14.00$140,000.00 7/16/2024Richard E LowenthalCEOSell100,000$11.40$1,140,000.00 7/9/2024Sarina TanimotoInsiderSell100,000$9.62$962,000.00 6/12/2024Sarina TanimotoInsiderSell95,862$9.15$877,137.30 6/11/2024Richard E LowenthalCEOSell4,138$9.00$37,242.00 (Data available from 1/1/2013 forward) SPRY Insider Trading Activity - Frequently Asked Questions Who is on ARS Pharmaceuticals's Insider Roster? The list of insiders at ARS Pharmaceuticals includes Alexander A Fitzpatrick, Brent L. Saunders, Brian Dorsey, Eric Karas, James E Flynn, Justin Chakma, Kathleen D Scott, Laura Shawver, Peter A Thompson, Ra Capital Management, L.P., Richard E Lowenthal, and Sarina Tanimoto. Learn more on insiders at SPRY. What percentage of ARS Pharmaceuticals stock is owned by insiders? 33.50% of ARS Pharmaceuticals stock is owned by insiders. Learn more on SPRY's insider holdings. Which ARS Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SPRY shares in the last 24 months: Alexander A Fitzpatrick ($144,800.00), and Ra Capital Management, L.P. ($40,348,945.66). How much insider buying is happening at ARS Pharmaceuticals? Insiders have purchased a total of 7,433,554 SPRY shares in the last 24 months for a total of $40,493,745.66 bought. Which ARS Pharmaceuticals insiders have been selling company stock? The following insiders have sold SPRY shares in the last 24 months: Alexander A Fitzpatrick ($1,451,862.90), Brent L. Saunders ($1,710,000.00), Brian Dorsey ($1,057,500.00), Eric Karas ($420,000.00), James E Flynn ($9,533,346.24), Justin Chakma ($2,453,096.32), Kathleen D Scott ($1,105,000.00), Laura Shawver ($5,415,597.15), Peter A Thompson ($7,522,032.00), Richard E Lowenthal ($8,164,888.41), and Sarina Tanimoto ($9,453,632.05). How much insider selling is happening at ARS Pharmaceuticals? Insiders have sold a total of 3,802,492 ARS Pharmaceuticals shares in the last 24 months for a total of $48,286,955.07 sold. ARS Pharmaceuticals Key ExecutivesMr. Richard Lowenthal M.B.A. (Age 58)M.S., MSMSEL, Founder, President, CEO & Director Compensation: $2.75MDr. Sarina Tanimoto M.B.A. (Age 55)M.D., Co-Founder & Chief Medical Officer Compensation: $2.47MMr. Alexander A. Fitzpatrick Esq. (Age 57)Chief Legal Officer & Secretary Compensation: $677.14k1 recent tradesDr. Robert Bell Ph.D.Co-Founder & Chief Science OfficerMs. Kathleen D. Scott CPAChief Financial Officer1 recent tradesMr. Brian T. Dorsey M.S. (Age 55)Chief Operations Officer Mr. Daniel RelovskySenior Vice President of MarketingMr. Harris Kaplan M.B.A. (Age 72)Executive Vice President of Commercial Strategy Mr. Eric Karas (Age 51)Chief Commercial Officer Compensation: $618.61k1 recent tradesMr. Justin Chakma (Age 34)Chief Business Officer & Secretary 1 recent trades More Insider Trading Tools from MarketBeat Related Companies TGTX Insider Trading NUVL Insider Trading LNTH Insider Trading AXSM Insider Trading ADMA Insider Trading PCVX Insider Trading MRUS Insider Trading RYTM Insider Trading AKRO Insider Trading RNA Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite Disparity This page (NASDAQ:SPRY) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPRY Stock Free SPRY Stock Alerts